Danilo Wegner

Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans

K. May, Danilo Wegner, Ute Hecker et al. · Clinical Pharmacology & Therapeutics · 2004 · 166 citations

Medicine, Pharmacokinetics, Pharmacology +17

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol

Sierk Haenisch, Karen May, Danilo Wegner et al. · Pharmacogenetics and Genomics · 2008 · 86 citations

Veterinary Medicine, Genetics, Pharmacology +14

Targeted adsorption of molecules in the colon with the novel adsorbent‐based Medicinal Product, DAV132: A proof of concept study in healthy subjects

Jean de Gunzburg, Annie Ducher, Danilo Wegner et al. · The Journal of Clinical Pharmacology · 2014 · 72 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

The Talinolol Double-Peak Phenomenon Is Likely Caused by Presystemic Processing After Uptake from Gut Lumen

Werner Weitschies, Annika Bernsdorf, M Zschiesche et al. · Pharmaceutical Research · 2005 · 69 citations

Pharmacy, Biochemistry, Endocytosis +6

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Nikolai Siebert, Christin Eger, Diana Seidel et al. · mAbs · 2016 · 56 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15